{"id":296030,"date":"2023-12-05T00:00:00","date_gmt":"2023-12-05T00:00:00","guid":{"rendered":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/acreim0029-2023-biopharma-crohns-disease-access-reimbursement-access-reimbursement-impacts-of\/"},"modified":"2026-03-31T10:31:42","modified_gmt":"2026-03-31T10:31:42","slug":"acreim0029-2023-biopharma-crohns-disease-access-reimbursement-access-reimbursement-impacts-of-biosimilar","status":"publish","type":"report","link":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/acreim0029-2023-biopharma-crohns-disease-access-reimbursement-access-reimbursement-impacts-of-biosimilar\/","title":{"rendered":"Crohn’s Disease – Access & Reimbursement – Access & Reimbursement \u2013 Impacts of Biosimilar Adalimumab Launches in Autoimmune Disease (US)"},"content":{"rendered":"","protected":false},"template":"","class_list":["post-296030","report","type-report","status-publish","hentry","report-gateway-biopharma","biopharma-therapy-areas-crohns-disease","biopharma-therapy-areas-gastrointestinal","biopharma-product-biosimilars","biopharma-geography-us","biopharma-date-975"],"acf":[],"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/296030","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report"}],"about":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/types\/report"}],"version-history":[{"count":10,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/296030\/revisions"}],"predecessor-version":[{"id":576031,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/296030\/revisions\/576031"}],"wp:attachment":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/media?parent=296030"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}